PL1910398T3 - 17-alfa-podstawione pochodne estradiolu wykazujące działanie gojenia ran - Google Patents
17-alfa-podstawione pochodne estradiolu wykazujące działanie gojenia ranInfo
- Publication number
- PL1910398T3 PL1910398T3 PL06762874T PL06762874T PL1910398T3 PL 1910398 T3 PL1910398 T3 PL 1910398T3 PL 06762874 T PL06762874 T PL 06762874T PL 06762874 T PL06762874 T PL 06762874T PL 1910398 T3 PL1910398 T3 PL 1910398T3
- Authority
- PL
- Poland
- Prior art keywords
- estradiol
- alpha
- wound
- substituted derivatives
- healing activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001516A ITMI20051516A1 (it) | 2005-08-02 | 2005-08-02 | Derivati 17 alfa-sostituti dell'estradiolo ad attivita' cicatrizzante |
EP06762874A EP1910398B1 (en) | 2005-08-02 | 2006-07-28 | 17-alpha-substituted derivatives of estradiol with wound-healing activity |
PCT/EP2006/007488 WO2007014711A1 (en) | 2005-08-02 | 2006-07-28 | 17-alpha-substituted derivatives of estradiol with wound-healing activity |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1910398T3 true PL1910398T3 (pl) | 2011-05-31 |
Family
ID=37564355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06762874T PL1910398T3 (pl) | 2005-08-02 | 2006-07-28 | 17-alfa-podstawione pochodne estradiolu wykazujące działanie gojenia ran |
Country Status (10)
Country | Link |
---|---|
US (1) | US8357675B2 (pl) |
EP (1) | EP1910398B1 (pl) |
AT (1) | ATE489398T1 (pl) |
DE (1) | DE602006018471D1 (pl) |
DK (1) | DK1910398T3 (pl) |
ES (1) | ES2356668T3 (pl) |
IT (1) | ITMI20051516A1 (pl) |
PL (1) | PL1910398T3 (pl) |
PT (1) | PT1910398E (pl) |
WO (1) | WO2007014711A1 (pl) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1806131A3 (en) | 1996-07-22 | 2007-08-01 | Renovo Limited | Use of sex steroid function modulators to treat wounds and fibrotic disorders |
-
2005
- 2005-08-02 IT IT001516A patent/ITMI20051516A1/it unknown
-
2006
- 2006-07-28 ES ES06762874T patent/ES2356668T3/es active Active
- 2006-07-28 AT AT06762874T patent/ATE489398T1/de active
- 2006-07-28 PL PL06762874T patent/PL1910398T3/pl unknown
- 2006-07-28 WO PCT/EP2006/007488 patent/WO2007014711A1/en active Application Filing
- 2006-07-28 DK DK06762874.3T patent/DK1910398T3/da active
- 2006-07-28 DE DE602006018471T patent/DE602006018471D1/de active Active
- 2006-07-28 US US11/989,807 patent/US8357675B2/en active Active
- 2006-07-28 PT PT06762874T patent/PT1910398E/pt unknown
- 2006-07-28 EP EP06762874A patent/EP1910398B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1910398A1 (en) | 2008-04-16 |
EP1910398B1 (en) | 2010-11-24 |
DK1910398T3 (da) | 2011-02-14 |
DE602006018471D1 (de) | 2011-01-05 |
WO2007014711A1 (en) | 2007-02-08 |
US8357675B2 (en) | 2013-01-22 |
US20100035796A1 (en) | 2010-02-11 |
ES2356668T3 (es) | 2011-04-12 |
PT1910398E (pt) | 2011-02-25 |
ITMI20051516A1 (it) | 2007-02-03 |
ATE489398T1 (de) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1054332A1 (zh) | 具有全身效應的新型局部雌激素孕激素組合物 | |
CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
HK1077208A1 (en) | Topical composition containing at least one vitminD or one vitamin D analogue and at least one cort icosteroid | |
RS20060348A (en) | Extended use combination comprising estrogens and progestins | |
WO2005077968A8 (en) | 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity | |
TW200837074A (en) | Extended triterpene derivatives | |
AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
PE20080273A1 (es) | Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico | |
CR10838A (es) | Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
CR10732A (es) | Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina | |
WO2008075320A3 (en) | Antilipidemic pharmaceutical compositions and process for preparation thereof | |
SI1987063T1 (sl) | Peptidi in peptidni derivati, njihova priprava in tudi njihova uporaba za pripravo terapevtsko in/ali profilaktično aktivnega farmacevtskega sestavka | |
WO2005011617A3 (en) | Transmucosal dosage forms for brain-targeted steroid chemical delivery systems | |
IL186058A0 (en) | Polymorphs of 3-0-(3',3' -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt | |
RS90504A (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
PL1910398T3 (pl) | 17-alfa-podstawione pochodne estradiolu wykazujące działanie gojenia ran | |
EP1857111A3 (en) | Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis | |
EA200900829A1 (ru) | Фармацевтический препарат для уменьшения эндометриоза | |
WO2005013945A3 (en) | Medicaments for inhalation comprising steroids and a betamimetic | |
UA85190C2 (en) | PROCESS FOR THE SYNTHESIS OF PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS AND THE MIXTURE OF ISOMERS, AND USE OF THOSE ISOMERS | |
UA90241C2 (ru) | Противовоспалительная и болеутоляющая композиция для местного применения в участке опорно-двигательной системы животных | |
RU2009140372A (ru) | Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима | |
PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa |